We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cell Culture of Glioma Specimens for in Vitro Preclinical Studies

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2009 by Albany Medical College.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01125826
First Posted: May 19, 2010
Last Update Posted: June 27, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Albany Medical College
May 18, 2010
May 19, 2010
June 27, 2011
April 2009
April 2012   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01125826 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cell Culture of Glioma Specimens for in Vitro Preclinical Studies
Primary Cell Culture of Surgical Glioma Specimens for Invitro Preclinical Studies

The purpose of this study is to culture primary human brain tumor cells with the specific aims of:

  1. Develop primary cultures from human brain tumor surgical specimens
  2. Determine the genetic and molecular fingerprints of brain tumors that may have prognostic significance
  3. Delineate the mechanisms underlying oncogenesis of brain tumors.
  4. Perform in vitro assays with brain tumor derived primary cultures to assess the efficacy of novel therapeutic agents.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
All subjects will be give permission for specimen storage by signing a separate permission on the informed consent. All specimens will be stored at a tissue bank for an unspecified amount of time.
Probability Sample
Patients 18 years of age or older undergoing surgical resection for gliomas.
Brain Tumor
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
50
June 2012
April 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients 18 years of age or older undergoing surgical resection for glioma

Exclusion Criteria:

  • Under 18 years of age
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01125826
2536
No
Not Provided
Not Provided
Yu-Hung Kuo, MD, Neurosciences Institute, Albany Medical College
Albany Medical College
Not Provided
Not Provided
Albany Medical College
April 2009